Literature DB >> 18370187

Application of electroporation gene therapy: past, current, and future.

Lluis M Mir1.   

Abstract

Twenty-five years after the publication of the first report on gene transfer in vitro in cultured cells by the means of electric pulse delivery, reversible cell electroporation for gene transfer and gene therapy (DNA electrotransfer) is at a crossroad in its development. Present knowledge on the effects of cell exposure to appropriate electric field pulses, particularly at the level of the cell membrane, is reported here as an introduction to the large range of applications described in this book. The importance of the models of electric field distribution in tissues and of the correct choice of electrodes and applied voltages is highlighted. The mechanisms involved in DNA electrotransfer, which include cell electropermeabilization and DNA electrophoresis, are also surveyed. The feasibility of electric pulse for gene transfer in humans is discussed taking into account that electric pulse delivery is already regularly used for localized drug delivery in the treatment of cutaneous and subcutaneous solid tumors by electrochemotherapy. Because recent technological developments have made DNA electrotransfer more efficient and safer, this nonviral gene therapy approach is now ready to reach the clinical stage. A good understanding of DNA electrotransfer principles and a respect for safe procedures will be key elements for the successful future transition of DNA electrotransfer to the clinics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18370187     DOI: 10.1007/978-1-59745-194-9_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Suprachoroidal electrotransfer: a nonviral gene delivery method to transfect the choroid and the retina without detaching the retina.

Authors:  Elodie Touchard; Marianne Berdugo; Pascal Bigey; Mohamed El Sanharawi; Michèle Savoldelli; Marie-Christine Naud; Jean-Claude Jeanny; Francine Behar-Cohen
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

Review 2.  What is (still not) known of the mechanism by which electroporation mediates gene transfer and expression in cells and tissues.

Authors:  Jean-Michel Escoffre; Thomas Portet; Luc Wasungu; Justin Teissié; David Dean; Marie-Pierre Rols
Journal:  Mol Biotechnol       Date:  2008-11-18       Impact factor: 2.695

Review 3.  Microscale electroporation: challenges and perspectives for clinical applications.

Authors:  Won Gu Lee; Utkan Demirci; Ali Khademhosseini
Journal:  Integr Biol (Camb)       Date:  2009-01-29       Impact factor: 2.192

4.  Transfection of mouse cochlear explants by electroporation.

Authors:  Elizabeth C Driver; Matthew W Kelley
Journal:  Curr Protoc Neurosci       Date:  2010-04

Review 5.  Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.

Authors:  Christophe Pichavant; Annemieke Aartsma-Rus; Paula R Clemens; Kay E Davies; George Dickson; Shin'ichi Takeda; Steve D Wilton; Jon A Wolff; Christine I Wooddell; Xiao Xiao; Jacques P Tremblay
Journal:  Mol Ther       Date:  2011-04-05       Impact factor: 11.454

6.  Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs.

Authors:  S D Reed; A Fulmer; J Buckholz; B Zhang; J Cutrera; K Shiomitsu; S Li
Journal:  Cancer Gene Ther       Date:  2010-02-12       Impact factor: 5.987

7.  Transfection optimization for primary human CD8+ cells.

Authors:  Lianxing Liu; Carl Johnson; Sue Fujimura; Fernando Teque; Jay A Levy
Journal:  J Immunol Methods       Date:  2011-07-18       Impact factor: 2.303

8.  Single-cell transfection by electroporation using an electrolyte/plasmid-filled capillary.

Authors:  Manyan Wang; Owe Orwar; Stephen G Weber
Journal:  Anal Chem       Date:  2009-05-15       Impact factor: 6.986

Review 9.  Electroporation advances in large animals.

Authors:  Scott D Reed; Shulin Li
Journal:  Curr Gene Ther       Date:  2009-08       Impact factor: 4.391

10.  Synergistic effects of nanosecond pulsed electric fields combined with low concentration of gemcitabine on human oral squamous cell carcinoma in vitro.

Authors:  Jing Wang; Jinsong Guo; Shan Wu; Hongqing Feng; Shujun Sun; Jie Pan; Jue Zhang; Stephen J Beebe
Journal:  PLoS One       Date:  2012-08-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.